HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xifeng Wu Selected Research

pyrene

6/2008BPDE induced lymphocytic chromosome 3p deletions may predict renal cell carcinoma risk.
7/2007Risk assessment of renal cell carcinoma using alkaline comet assay.
8/2002BPDE-induced lymphocytic 3p21.3 aberrations may predict head and neck carcinoma risk.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xifeng Wu Research Topics

Disease

153Neoplasms (Cancer)
10/2021 - 01/2002
75Lung Neoplasms (Lung Cancer)
01/2021 - 01/2002
53Urinary Bladder Neoplasms (Bladder Cancer)
03/2018 - 02/2003
28Carcinogenesis
11/2018 - 07/2002
25Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020 - 04/2005
20Adenocarcinoma
01/2018 - 12/2005
17Renal Cell Carcinoma (Grawitz Tumor)
01/2021 - 07/2007
17Genetic Predisposition to Disease (Genetic Predisposition)
01/2017 - 08/2002
13Ovarian Neoplasms (Ovarian Cancer)
01/2021 - 10/2007
12Inflammation (Inflammations)
01/2021 - 08/2004
11Esophageal Neoplasms (Esophageal Cancer)
04/2015 - 12/2005
8Colorectal Neoplasms (Colorectal Cancer)
12/2021 - 01/2012
8Breast Neoplasms (Breast Cancer)
01/2021 - 02/2015
8Non-Muscle Invasive Bladder Neoplasms
03/2018 - 10/2010
8Head and Neck Neoplasms (Head and Neck Cancer)
01/2013 - 01/2002
7Carcinoma (Carcinomatosis)
10/2014 - 08/2002
6Prostatic Neoplasms (Prostate Cancer)
03/2021 - 05/2008
6Obesity
01/2021 - 01/2016
5Hypertension (High Blood Pressure)
01/2022 - 02/2015
5Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 08/2016
5Hepatocellular Carcinoma (Hepatoma)
06/2018 - 09/2012
5Barrett Esophagus (Barrett's Esophagus)
09/2014 - 10/2006
5Pain (Aches)
11/2013 - 12/2007
5Squamous Cell Carcinoma of Head and Neck
07/2012 - 08/2002
4Ovarian Epithelial Carcinoma
01/2018 - 05/2014
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2017 - 12/2005
4Genomic Instability
04/2016 - 08/2004
4Fatigue
11/2013 - 12/2007
4Chromosome Breakage
03/2006 - 07/2002
3Fibrosis (Cirrhosis)
01/2019 - 01/2018
3Esophagitis
02/2016 - 08/2010
3Pneumonia (Pneumonitis)
02/2016 - 08/2010
3Colonic Neoplasms (Colon Cancer)
01/2016 - 08/2007
3Neoplasm Metastasis (Metastasis)
12/2013 - 04/2005
3Chromosome Aberrations (Chromosome Abnormalities)
05/2012 - 05/2002
2Chronic Disease (Chronic Diseases)
10/2021 - 01/2021

Drug/Important Bio-Agent (IBA)

49Biomarkers (Surrogate Marker)IBA
12/2021 - 01/2002
29MicroRNAs (MicroRNA)IBA
01/2019 - 04/2008
24MutagensIBA
01/2016 - 05/2002
23Biological ProductsIBA
01/2022 - 01/2004
23DNA (Deoxyribonucleic Acid)IBA
11/2020 - 01/2007
127,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxideIBA
09/2008 - 01/2002
11SmokeIBA
01/2022 - 08/2002
10CarcinogensIBA
11/2018 - 07/2002
10Epoxy Compounds (Epoxides)IBA
01/2011 - 04/2003
9Insulin (Novolin)FDA Link
01/2022 - 02/2003
9ORALIT (ORS)IBA
01/2021 - 05/2002
9Mitochondrial DNA (mtDNA)IBA
05/2018 - 08/2008
9Messenger RNA (mRNA)IBA
01/2018 - 05/2004
9PlatinumIBA
01/2017 - 01/2006
9EnzymesIBA
01/2013 - 07/2002
9Benzo(a)pyreneIBA
01/2011 - 07/2002
8Proteins (Proteins, Gene)FDA Link
11/2019 - 06/2006
7CytokinesIBA
01/2021 - 12/2007
7Insulin-Like PeptidesIBA
01/2013 - 08/2002
7Bleomycin (Blenoxane)FDA LinkGeneric
01/2011 - 07/2002
6Telomerase (Telomerase Reverse Transcriptase)IBA
06/2018 - 03/2007
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2019 - 05/2005
5Folic Acid (Vitamin M)FDA LinkGeneric
01/2018 - 09/2004
5Interleukin-8 (Interleukin 8)IBA
01/2017 - 12/2007
5Pharmaceutical PreparationsIBA
10/2016 - 12/2005
51,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA
02/2016 - 06/2008
5Matrix Metalloproteinases (MMPs)IBA
06/2015 - 08/2004
5Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
11/2012 - 05/2008
5Carrier Proteins (Binding Protein)IBA
01/2012 - 08/2002
4LigandsIBA
01/2021 - 03/2003
4BilirubinIBA
12/2020 - 01/2015
4Interleukin-6 (Interleukin 6)IBA
10/2019 - 05/2005
4Hormones (Hormone)IBA
10/2019 - 09/2005
4Genetic Markers (Genetic Marker)IBA
01/2019 - 01/2012
4P-2 (P 2)IBA
01/2017 - 10/2010
4Cyclooxygenase 2 (Cyclooxygenase-2)IBA
11/2013 - 04/2009
4GTP-Binding Proteins (G-Protein)IBA
05/2013 - 01/2007
4Glutathione Transferase (Glutathione S-Transferase)IBA
01/2013 - 04/2003
4AntigensIBA
03/2012 - 08/2007
4Peroxidase (Myeloperoxidase)IBA
02/2007 - 07/2002
4Insulin-Like Growth Factor I (IGF-1)IBA
06/2004 - 11/2002
3RNA (Ribonucleic Acid)IBA
01/2021 - 05/2004
3LeptinIBA
01/2021 - 10/2019
3Proline (L-Proline)FDA Link
08/2019 - 04/2015
3Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2019 - 10/2012
3Glucose (Dextrose)FDA LinkGeneric
01/2019 - 03/2016
3Transforming Growth Factors (Transforming Growth Factor)IBA
01/2018 - 01/2011
3Transforming Growth Factor beta (TGF-beta)IBA
01/2018 - 07/2011
3Transcription Factors (Transcription Factor)IBA
10/2017 - 01/2015
3Cisplatin (Platino)FDA LinkGeneric
10/2016 - 11/2008
3NucleotidesIBA
01/2016 - 08/2007
3ImmunosorbentsIBA
01/2013 - 02/2003
3Phosphotransferases (Kinase)IBA
04/2012 - 12/2009
3TOR Serine-Threonine KinasesIBA
08/2010 - 02/2009
3pyreneIBA
06/2008 - 08/2002
2Uric Acid (Urate)IBA
07/2022 - 01/2018
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2021 - 01/2018

Therapy/Procedure

24Therapeutics
01/2021 - 01/2004
19Drug Therapy (Chemotherapy)
12/2017 - 04/2005
7Immunotherapy
01/2020 - 06/2009
7Radiotherapy
02/2016 - 04/2005
6Chemoprevention
07/2012 - 06/2004
5Chemoradiotherapy
05/2011 - 04/2005
3Adjuvant Chemotherapy
01/2015 - 01/2012